Skip to main content

Table 2 Genetic data, clinical features, and MRI findings of patients in this study

From: A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly

 

Patient1

Patient2

Patient3

Patient4

Patient5

Patient6

Patient7

Patient8

Patient9

Patient10

Patient11

Patien12

Patient13

Age

3y0m

2y3m

6y8 m

4y2m

4y9m

4y6m

16y

4y8 m

7y4m

9y

2y10m

3y6m

2y0m

Sex

F

M

M

F

F

F

M

M

M

M

M

M

M

Elevated p-S6 protein (Relative density)

+ (3.4)

+ (3.0)

+ (3.8)

+ (3.6)

ND

+ (2.1)

+ (2.1)

+ (2.8)

+ (2.6)

- (0.8)

- (0.9)

- (1.1)

- (1.0)

Gene

AKT3

PIK3R2

PIK3R2

PTEN

PTEN

PTEN

-

-

-

-

-

-

-

Mutation

c.686A > G p.(N229S)

c.1117G > A p.(G373R)

c.1117G > A p.(G373R)

c.640C > T p.(Q214*)

c.740 T > C p.(L247S)

c.1006C > G p.(Y336*)

Unknown

Unknown

Unknown

Unknown

Unknown

Unknown

Unknown

Inheritance

de novo

de novo

de novo

Mother negative

de novo

de novo

-

-

-

-

-

-

-

Clinical features

 Gestational age

36w5d

36w6d

40w1d

37w4d

38w6d

39w5d

36w6d

36w5d

41w0d

38w1d

39w

38w6d

38w3d

 Birth weight g (SD)a

2942 (+1.4)

3450 (+2.7)

3532 (+1.2)

2536 (−0.3)

2854 (+0)

3200 (+0.7)

2915 (+1.0)

3490 (+3.0)

2464 (−2.3)

3885 (+3.3)

3830 (+2.6)

4120 (+3.5)

3866 (+3.0)

 Birth length cm (SD)a

47.5 (+0.3)

49.2 (+1.0)

52.5 (+1.4)

47 (−0.4)

50 (+0.7)

51 (+1.0)

48 (+0.4)

48.8 (+0.9)

47 (−1.6)

50.6 (+1.3)

NA

NA

48.4 (+0)

 Birth OFC cm (SD)a

39 (+4.9)

36 (+2.5)

34 (+0.4)

33 (+0.1)

33 (−0.1)

34 (+0.5)

35 (+1.8)

37 (+3.3)

30 (−2.0)

41 (+6.4)

36.5 (+3.0)

37 (+3.0)

39 (+4.6)

 Birth OFC percentile a

>99

>99

67

53

44

70

96

>99

2

>99

>99

>99

>99

 Last weight SDb

−1.9

0

−2.3

+0.4

−0.7

+0.8

−2.6

−0.2

−1.2

−0.2

+2.8

+2.2

+1.4

 Last length SDb

−2.0

−0.2

−2.8

−0.4

−1.9

+0.2

−3.3

−1.3

−2.7

1.1

+0.7

−1.8

+0.2

 Last OFC SDc

+6.3

+4.6

+3.0

+4.5

+4.3

+3.5

+4.9

+4.6

+2.0

+8.5

+5.4

+3.8

+4.5

 Last OFC percentile c

>99

>99

>99

>99

>99

>99

>99

>99

98

>99

>99

>99

>99

 Overgrowth /Asymmetry

-

+

-

-

-

-

-

-

-

+

-

+

-

 Vascular malformations

-

-

-

-

-

-

-

-

-

+

-

-

+

 Syndactyly

-

-

-

-

-

-

-

-

-

-

-

-

-

 Polydactyly

-

-

-

-

-

-

+

-

-

+

-

+

-

 Connective tissue dysplasia

-

+

-

-

-

-

-

-

+

-

-

-

-

 Dysmorphic features

+

+

+

+

+

+

+

+

+

+

+

+

+

 DQ (assessed method) age

DD

DQ 42 (Denver) 10 m

DD

DQ 76 (KIDS) 2y5m

DQ 85 (KIDS) 4y6m

DQ 59 (K-test) 4y1m

DQ 12 (KIDS) 6y6m

DQ 71 (K-test) 6y8 m

DQ 35 (KIDS) 5y9m

DD

DQ 72 (K-test) 3y0m

DQ 46 (K-test) 1y7m

NA

 Meaningful words

-

-

-

1y6m

8 m

2y6m

+

2y

-

+

2y

-

-

 Walking alone

-

-

-

2y4m

2y2m

1y6m

+

1y11m

1y11m

4y6m

1y6m

2y3m

1y3m

 Hypotonia

+

+

+

-

+

-

+

+

+

-

-

+

+

 Seizure

+

-

+

-

-

-

+

-

-

-

-

-

-

MRI findings

 Ventriculomegaly

+

+

+

-

-

-

+

+

-

+

+

+

+

 Polymicrogyria

+

+

+

-

-

-

+

-

-

+

-

+

-

 Cerebellar tonsillar ectopia

-

-

-

-

-

-

-

+

-

+

-

+

-

 White matter abnormalities

+

+

+

-

-

-

-

-

-

+

-

+

-

  1. aSD and percentile were determined on the basis of the national data reported by the Ministry of Health, Welfare, and Labor in Japan in 2010
  2. bSD was determined on the basis of the national data reported by the Ministry of Health, Welfare, and Labor in Japan in 2000
  3. cSD and percentile were determined on the basis of CDC growth Charts for the United States in 2000
  4. DD apparently developmentally delayed but not scored by a standardized method, Denver Denver Developmental Screening Test, DQ developmental quotient, F female, KIDS Kinder Infant Development Scale, K-test the revised version of Kyoto Scale of Psychological Development, M male, NA not available, OFC occipitofrontal circumference, p-S6 phosphorylated S6 protein, SD, standard deviation
  5. Accession number.: AKT3, NM_005465.4; PIK3R2, NM_005027.3; PTEN, NM_000314.5